Mauri K Hodges
CIK 1489773 · View on SEC EDGAR ↗
First SEC filing: Dec. 18, 2014 · Latest: Dec. 18, 2014
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 9, 2011 | GYRE | S | 1,500 | $30.00 | $45,000 | 1,159 Direct | -56.41% | Disposed | -100.0% (price as of 2026-08-21) |
| March 7, 2011 | GYRE | S | 500 | $30.00 | $15,000 | 1,159 Direct | -30.14% | Disposed | -100.0% (price as of 2026-08-21) |
| March 3, 2011 | GYRE | S | 5,030 | $30.00 | $150,900 | 1,159 Direct | -81.27% | Disposed | -100.0% (price as of 2026-08-21) |
| March 2, 2011 | GYRE | S | 200 | $30.00 | $6,000 | 1,159 Direct | -14.72% | Disposed | -100.0% (price as of 2026-08-21) |
| March 1, 2011 | GYRE | S | 12,703 | $30.16 | $383,122 | 1,159 Direct | -91.64% | Disposed | -100.0% (price as of 2026-08-21) |
| Dec. 16, 2010 | GYRE | S | 2,700 | $25.24 | $68,148 | 1,159 Direct | -69.97% | Disposed | -100.0% (price as of 2026-08-21) |
| Nov. 5, 2010 | GYRE | S | 1,400 | $25.01 | $35,014 | 1,159 Direct | -54.71% | Disposed | -100.0% (price as of 2026-08-21) |
| Nov. 4, 2010 | GYRE | S | 7,800 | $25.08 | $195,624 | 1,159 Direct | -87.06% | Disposed | -100.0% (price as of 2026-08-21) |
| Nov. 3, 2010 | GYRE | S | 1,000 | $25.06 | $25,060 | 1,159 Direct | -46.32% | Disposed | -100.0% (price as of 2026-08-21) |
| May 13, 2010 | GYRE | S | 1,402 | $25.00 | $35,050 | 1,159 Direct | -54.74% | Disposed | -100.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 14, 2015 | GYRE | Redeemable Convertible Note | Common Stock (33,981) | $1.31 | — | — | Acquired |
| Jan. 17, 2013 | GYRE | Stock Option (Right to Buy) | Common Stock (40,000) | $4.63 | Jan. 16, 2023 | 40,000 | Acquired |
| May 4, 2012 | GYRE | Stock Option (Right to Buy) | Common Stock (60,000) | $4.59 | May 3, 2022 | 60,000 | Acquired |
| March 29, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (30,500) | $26.05 | March 28, 2021 | 30,500 | Acquired |
| March 9, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (1,500) | $5.55 | Aug. 15, 2016 | 1,500 | Disposed |
| March 7, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (500) | $5.55 | Aug. 15, 2016 | 500 | Disposed |
| March 3, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (5,030) | $5.55 | Aug. 15, 2016 | 5,030 | Disposed |
| March 2, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (200) | $5.55 | Aug. 15, 2016 | 200 | Disposed |
| March 1, 2011 | GYRE | Stock Option (Right to Buy) | Common Stock (12,703) | $5.55 | Aug. 15, 2016 | 12,703 | Disposed |
| Dec. 16, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (2,700) | $8.51 | Dec. 18, 2017 | 2,700 | Disposed |
| Nov. 5, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (1,400) | $8.51 | Dec. 18, 2017 | 1,400 | Disposed |
| Nov. 4, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (7,800) | $8.51 | Dec. 18, 2017 | 7,800 | Disposed |
| Nov. 3, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (1,000) | $8.51 | Dec. 18, 2017 | 1,000 | Disposed |
| May 13, 2010 | GYRE | Stock Option (Right to Buy) | Common Stock (1,402) | $8.51 | Dec. 18, 2017 | 1,402 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 15 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 18, 2014 | GYRE | Common Stock | 41,259 | Direct |
| Dec. 18, 2014 | GYRE | Stock Option (right to buy)→ Common Stock (40,000) | 40,000 | Direct |
| Dec. 16, 2014 | GYRE | Common Stock | 1,159 | Direct |
| Dec. 16, 2014 | GYRE | Employee Stock Option (right to buy)→ Common Stock (6,198) | 6,198 | Direct |
| Dec. 16, 2014 | GYRE | Employee Stock Option (right to buy)→ Common Stock (18,390) | 18,390 | Direct |
| Dec. 16, 2014 | GYRE | Employee Stock Option (right to buy)→ Common Stock (28,001) | 28,001 | Direct |
| Dec. 16, 2014 | GYRE | Employee Stock Option (right to buy)→ Common Stock (35,000) | 35,000 | Direct |
| Dec. 16, 2014 | GYRE | Stock Option (right to buy)→ Common Stock (30,500) | 30,500 | Direct |
| Dec. 16, 2014 | GYRE | Stock Option (right to buy)→ Common Stock (60,000) | 60,000 | Direct |
| Dec. 16, 2014 | GYRE | Stock Option (right to buy)→ Common Stock (40,000) | 40,000 | Direct |
| April 22, 2010 | GYRE | Common Stock | 1,159 | Direct |
| April 22, 2010 | GYRE | Employee Stock Option (right to buy)→ Common Stock (26,131) | 26,131 | Direct |
| April 22, 2010 | GYRE | Employee Stock Option (right to buy)→ Common Stock (32,692) | 32,692 | Direct |
| April 22, 2010 | GYRE | Employee Stock Option (right to buy)→ Common Stock (28,001) | 28,001 | Direct |
| April 22, 2010 | GYRE | Employee Stock Option (right to buy)→ Common Stock (35,000) | 35,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2015 | $225,000 | — | — | — | — | — | $479,632 | $704,632 |
| 2014 | $258,523 | $35,435 | — | — | — | — | $10,400 | $537,958 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.